Results of Cost-Effectiveness and Cost-Utility Analyses for Vitality Study at End of Intervention and Follow-Up
CAD
REGRESSION, CAD
Abbreviations: ICER, incremental cost-effectiveness ratio; ICUR, incremental cost-utility ratio; NA, not applicable; QALY, quality-adjusted life-year.There is no willingness-to-pay threshold for which we can be 95% confident that the 2 therapies differed in value.QALYs are adjusted for baseline utility using a linear regression model.Expressed as estimate (95% CI), with 95% CIs indicating that for willingness-to-pay threshold of at least CAD $0 and no more than CAD $14 589, we can be 95% confident that the therapy with the larger point estimate for effect represents good value compared with the alternative.Expressed as estimate (95% CI), with 95% CIs indicating that there is no willingness-to-pay threshold for which we can be 95% confident that the 2 therapies differ in value.